K

Knight Therapeutics Inc
TSX:GUD

Watchlist Manager
Knight Therapeutics Inc
TSX:GUD
Watchlist
Price: 5.77 CAD -0.52% Market Closed
Market Cap: 573.8m CAD

Wall Street
Price Targets

GUD Price Targets Summary
Knight Therapeutics Inc

Wall Street analysts forecast GUD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GUD is 7.71 CAD with a low forecast of 6.51 CAD and a high forecast of 9.45 CAD.

Lowest
Price Target
6.51 CAD
13% Upside
Average
Price Target
7.71 CAD
34% Upside
Highest
Price Target
9.45 CAD
64% Upside
Knight Therapeutics Inc Competitors:
Price Targets
600420
Shanghai Shyndec Pharmaceutical Co Ltd
89% Upside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
21% Upside
PHO
Photocure ASA
68% Upside
IPCALAB
IPCA Laboratories Ltd
16% Upside
GPCR
Structure Therapeutics Inc
225% Upside
ARVN
Arvinas Inc
211% Upside
INDOCO
Indoco Remedies Ltd
24% Upside
LUPIN
Lupin Ltd
13% Upside

Revenue
Forecast

Revenue Estimate
Knight Therapeutics Inc

For the last 8 years the compound annual growth rate for Knight Therapeutics Inc's revenue is 68%. The projected CAGR for the next 3 years is 7%.

68%
Past Growth
7%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Knight Therapeutics Inc

The compound annual growth rate of Knight Therapeutics Inc's operating income for the next 3 years is 20%.

N/A
Past Growth
20%
Estimated Growth
Estimates Accuracy
72%
Average Beat

Net Income
Forecast

Net Income Estimate
Knight Therapeutics Inc

For the last 8 years the compound annual growth rate for Knight Therapeutics Inc's net income is -17%. The projected CAGR for the next 3 years is 23%.

-17%
Past Growth
23%
Estimated Growth
Estimates Accuracy
45%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GUD's stock price target?
Price Target
7.71 CAD

According to Wall Street analysts, the average 1-year price target for GUD is 7.71 CAD with a low forecast of 6.51 CAD and a high forecast of 9.45 CAD.

What is Knight Therapeutics Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Knight Therapeutics Inc's revenue is 68%. The projected CAGR for the next 3 years is 7%.

What is Knight Therapeutics Inc's Operating Income forecast?
Projected CAGR
20%

The compound annual growth rate of Knight Therapeutics Inc's operating income for the next 3 years is 20%.

What is Knight Therapeutics Inc's Net Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Knight Therapeutics Inc's net income is -17%. The projected CAGR for the next 3 years is 23%.

Back to Top